InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ORAMED PHARMACEUTICALS INC.

ORMP Clue Score47
United States Fiscal year ends December CIK 0001176309
$4.27 -1.39% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.27 −81.63% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue2.5Operating income−10.8Net income−10.5Fiscal year 2018Revenue2.4 −0.3%Operating income−13.5Net income−12.7Fiscal year 2019Revenue2.7 +10.4%Operating income−14.6Net income−14.4Fiscal year 2020Revenue2.7 +0.3%Operating income−11.8Net income−11.5Fiscal year 2021Revenue2.7 −0.3%Operating income−24.2Net income−23.0Fiscal year 2022Revenue2.7 +0.0%Operating income−40.6Net income−36.6EPS, diluted−0.94Fiscal year 2023Revenue1.3 −50.4%Operating income−15.8Net income5.1EPS, diluted0.14Fiscal year 2024Operating income−12.8Net income−19.1 −474.6%EPS, diluted−0.48 −442.9%Fiscal year 2025Revenue2.0Operating income−15.1Net income64.1EPS, diluted1.50
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.5 2.4 2.7 2.7 2.7 2.7 1.3 n/a 2.0
Growth −0.3% +10.4% +0.3% −0.3% +0.0% −50.4%
Operating income −10.8 −13.5 −14.6 −11.8 −24.2 −40.6 −15.8 −12.8 −15.1
Net income −10.5 −12.7 −14.4 −11.5 −23.0 −36.6 5.1 −19.1 64.1
Growth −474.6%
EPS, diluted n/a n/a n/a n/a n/a −0.94 0.14 −0.48 1.50
Growth −442.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Operating margin−438.6%Net margin−426.7%Free cash flow margin−237.7%Fiscal year 2018Operating margin−552.3%Net margin−519.7%Free cash flow margin−598.7%Fiscal year 2019Operating margin−541.3%Net margin−531.1%Free cash flow margin−479.3%Fiscal year 2020Operating margin−433.8%Net margin−424.8%Free cash flow margin−462.1%Fiscal year 2021Operating margin−896.2%Net margin−850.5%Free cash flow margin−797.5%Fiscal year 2022Operating margin−1,502.0%Net margin−1,352.6%Free cash flow margin−1,051.2%Fiscal year 2023Operating margin−1,176.8%Net margin379.7%Free cash flow margin−787.2%Fiscal year 2024Fiscal year 2025Gross margin0.7%Operating margin−754.4%Net margin3,202.5%Free cash flow margin−457.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a n/a n/a 0.7%
Operating margin −438.6% −552.3% −541.3% −433.8% −896.2% −1,502.0% −1,176.8% n/a −754.4%
Net margin −426.7% −519.7% −531.1% −424.8% −850.5% −1,352.6% 379.7% n/a 3,202.5%
Free cash flow margin −237.7% −598.7% −479.3% −462.1% −797.5% −1,051.2% −787.2% n/a −457.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−5.8Capital expenditure−0.0Free cash flow−5.8Fiscal year 2018Operating cash flow−14.7Capital expenditure−0.0Free cash flow−14.7Fiscal year 2019Operating cash flow−12.9Capital expenditure−0.0Free cash flow−13.0Fiscal year 2020Operating cash flow−12.4Capital expenditure−0.1Free cash flow−12.5Fiscal year 2021Operating cash flow−21.2Capital expenditure−0.4Free cash flow−21.6Fiscal year 2022Operating cash flow−27.9Capital expenditure−0.5Free cash flow−28.4Fiscal year 2023Operating cash flow−10.3Capital expenditure−0.3Free cash flow−10.5Fiscal year 2024Operating cash flow−8.4Capital expenditure−0.0Free cash flow−8.4Buybacks−2.5Fiscal year 2025Operating cash flow−9.1Capital expenditure−0.0Free cash flow−9.2Buybacks−4.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.8 −14.7 −12.9 −12.4 −21.2 −27.9 −10.3 −8.4 −9.1
Capital expenditure −0.0 −0.0 −0.0 −0.1 −0.4 −0.5 −0.3 −0.0 −0.0
Free cash flow −5.8 −14.7 −13.0 −12.5 −21.6 −28.4 −10.5 −8.4 −9.2
Growth
Buybacks n/a n/a n/a n/a n/a n/a n/a −2.5 −4.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash4.0Shareholders’ equity19.2Fiscal year 2018Cash5.0Total debt11.4Net cash (debt)−6.4Shareholders’ equity31.1Debt to equity0.37Fiscal year 2019Cash3.3Total debt9.7Net cash (debt)−6.3Shareholders’ equity19.4Debt to equity0.50Fiscal year 2020Cash19.3Shareholders’ equity32.9Fiscal year 2021Cash77.2Total debt12.5Net cash (debt)64.7Shareholders’ equity115.8Debt to equity0.11Fiscal year 2022Cash40.5Total debt0.0Net cash (debt)40.4Shareholders’ equity151.8Debt to equity0.00Fiscal year 2023Cash9.1Shareholders’ equity163.8Fiscal year 2024Cash54.4Shareholders’ equity146.3Fiscal year 2025Cash45.9Shareholders’ equity199.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.0 5.0 3.3 19.3 77.2 40.5 9.1 54.4 45.9
Total debt n/a 11.4 9.7 n/a 12.5 0.0 n/a n/a n/a
Net cash (debt) n/a −6.4 −6.3 n/a 64.7 40.4 n/a n/a n/a
Shareholders’ equity 19.2 31.1 19.4 32.9 115.8 151.8 163.8 146.3 199.7
Debt to equity n/a 0.37 0.50 n/a 0.11 0.00 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Aug 2017 FY2018 31 Aug 2018 FY2019 31 Aug 2019 FY2020 31 Aug 2020 FY2021 31 Aug 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
2.5 2.4 2.7 2.7 2.7 2.7 1.3 n/a 2.0
Growth −0.3% +10.4% +0.3% −0.3% +0.0% −50.4%
0.2 −0.1 0.1 n/a n/a n/a n/a n/a 2.0
n/a n/a n/a n/a n/a n/a n/a n/a 0.0
Growth
10.3 12.0 13.5 10.2 21.0 27.6 9.0 6.3 6.4
2.8 4.1 3.7 4.2 5.9 13.8 8.4 6.5 8.7
−10.8 −13.5 −14.6 −11.8 −24.2 −40.6 −15.8 −12.8 −15.1
Growth
−10.1 −12.7 −14.1 −11.5 n/a −37.7 5.1 −15.9 75.3
0.4 n/a 0.3 n/a n/a 0.1 n/a 3.2 11.3
−10.5 −12.7 −14.4 −11.5 −23.0 −36.6 5.1 −19.1 64.1
Growth −474.6%
Per share
n/a n/a n/a n/a n/a −0.94 0.14 −0.48 1.53
n/a n/a n/a n/a n/a −0.94 0.14 −0.48 1.50
Growth −442.9%
n/a n/a n/a n/a n/a 39.0 40.3 40.9 41.4
n/a n/a n/a n/a n/a 39.0 40.6 40.9 42.4
Growth +4.0% +0.7% +3.8%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 5.8% a year over five years.
  • Operating margin is down 213.1 points on five years ago, at -754.4%.
  • A net loss in 7 of 9 years on file.